Lexeo Therapeutics, Inc. Financial Overview
Lexeo Therapeutics, Inc.'s market cap is currently $713.09M. The company's EPS TTM is $-0.33; its P/E ratio is ―; Lexeo Therapeutics, Inc. is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
